» Authors » Maya Balakrishnan

Maya Balakrishnan

Explore the profile of Maya Balakrishnan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 845
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Heredia N, Gaba R, Liu Y, Jain S, Rungta M, Rungta M, et al.
Sci Rep . 2022 Apr; 12(1):5695. PMID: 35383229
Weight loss through behavioral modification is central to treating non-alcoholic fatty liver disease (NAFLD). To achieve this, patients need to accurately self-perceive their health behaviors. We aimed to identify predictors...
12.
Heredia N, Zhang X, Balakrishnan M, Hwang J, Thrift A
Ethn Health . 2022 Jan; 28(2):299-312. PMID: 35067116
Objectives: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent liver disease, with the highest prevalence observed in the U.S. among Hispanic/Latino adults. While physical activity and dietary behaviors have...
13.
Heredia N, Zhang X, Balakrishnan M, Daniel C, Hwang J, McNeill L, et al.
Prev Med . 2021 Dec; 154:106903. PMID: 34861339
The association of physical activity (PA) and diet quality with non-alcoholic fatty liver disease (NAFLD) and NAFLD-related fibrosis have never been examined in a representative sample of U.S. adults using...
14.
15.
Balakrishnan M, K S
J Ayurveda Integr Med . 2021 Nov; 12(4):710-714. PMID: 34776324
Idiopathic granulomatous mastitis (IGM) is a chronic inflammatory disease of the breast which may present as painful, unilateral, discrete, breast masses with a tendency to recur. The pathogenesis is still...
16.
Heredia N, Thrift A, Balakrishnan M
Hisp Health Care Int . 2021 Oct; 20(3):171-178. PMID: 34658280
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a growing problem in the United States and Hispanics experience the highest burden of this disease. Weight loss, physical activity (PA) and a...
17.
Cheemerla S, Balakrishnan M
Clin Liver Dis (Hoboken) . 2021 Jun; 17(5):365-370. PMID: 34136143
No abstract available.
18.
Zhang X, Heredia N, Balakrishnan M, Thrift A
PLoS One . 2021 Jun; 16(6):e0252164. PMID: 34081733
Background: Non-alcoholic fatty liver disease (NAFLD) is increasingly common in the adult population. In the United States, the overall burden of NAFLD is unknown due to challenges with population-level NAFLD...
19.
Gianos E, Karalis D, Gaballa D, Paparodis R, Mintz G, Balakrishnan M, et al.
J Clin Lipidol . 2021 Apr; 15(3):423-430. PMID: 33836983
A recent rise in atherosclerotic cardiovascular disease (ASCVD) mortality in women warrants a heightened focus on the cardiometabolic risk factors that are closely tied to increasing trends in obesity and...
20.
Balakrishnan M, Falker C, Conley S, Ciarleglio M, Deng Y, Redeker N, et al.
Hepatol Commun . 2021 Mar; 5(3):491-501. PMID: 33681681
Disturbed sleep is common among patients with cirrhosis. The extent to which this is associated with the different stages of compensated cirrhosis is unknown. This study examines whether the presence...